Treatment of multiple sclerosis
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 31, 1987
Grant Date -
N/A
app pub date -
Feb 18, 1986
filing date -
Feb 18, 1986
priority date (Note) -
Expired
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
Multiple sclerosis is treated by the administration of azaspirane compounds, either germanium or silicon asaspirane compounds, preferably spirogermanium, most preferably dimethyl, diethyl, dipropyl or dibutyl. The diethyl or dibutyl are the most preferred.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully